IndiGo faces significant financial headwinds due to widespread flight cancellations extending through December, impacting revenue by an estimated 5-7%. The airline is also grappling with increased pilot costs due to new regulations. Analysts, however, view this as a temporary operational blip, with operations expected to stabilize within weeks.
SpiceJet shares spiked intraday as operational disruptions at rival IndiGo boosted demand for its services. Despite the short-term rally, the stock remains fundamentally weak, with bearish technical indicators, high promoter pledging, and declining institutional interest. Q2 FY25 results further reflected stress, with revenue falling sharply and losses widening.
Indian stock markets are at a key turning point. Experts predict a strong rally over the next two to three years, potentially delivering 40-50% returns. This optimism is driven by solid corporate earnings and economic growth. Sectors like consumption, industrials, and private banks are expected to lead. Foreign investors may return as valuations become more attractive.
Thailand launched air strikes on Cambodia after accusing its forces of violating a ceasefire, resulting in at least one Thai soldier's death. This escalation follows a previous peace deal brokered by Donald Trump, which had already broken down after deadly July clashes that displaced hundreds of thousands.
Speb Adhesives is set to debut on the NSE SME on December 8, following a moderately subscribed IPO. The company, a manufacturer of solvent-based synthetic rubber adhesives, raised funds for a new water-based adhesives facility. With steady financial growth and an expanding product range, market watchers will observe its listing performance.
Asian stocks opened cautiously as traders assessed strained China-Japan relations and upcoming central bank decisions. Investor caution grew regarding the AI rally's sustainability, with markets anticipating policy announcements from major central banks amid renewed inflation pressures. The Federal Reserve's rate path for 2026 remains uncertain, balancing price pressures and economic activity.
China's central bank continued its gold accumulation for the 13th consecutive month, adding 30,000 troy ounces in November. This sustained buying, which began in November 2024, coincides with gold's strong performance and expectations of Federal Reserve rate cuts. Global central bank purchases have also surged, driven by a need to hedge against the dollar.
Corona Remedies is set to raise 655.4 crore via an offer for sale. The company focuses on specialist doctors, driving faster revenue growth than the Indian pharmaceutical market. Its sales grew by 13.6% compared to the market's 7.9%. Revenue and net profit have shown strong annual growth. Investors with a high-risk appetite can consider this IPO for the long term.
